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ABSTRACT A three-dimensional multiscale computational model, platelet adhesive dynamics (PAD), is developed and applied
in Part I and Part II articles to characterize and quantify key biophysical aspects of GPIba-von-Willebrand-factor (vWF)-mediated
interplatelet binding at high shear rates, a necessary and enabling step that initiates shear-induced platelet aggregation. In this
article, an adhesive dynamics model of the transient aggregation of two unactivated platelets via GPIba-vWF-GPIba bridging is
developed and integrated with the three-dimensional hydrodynamic ﬂow model discussed in Part I. Platelet binding efﬁciencies
predicted by PAD are in good agreement with platelet aggregation behavior observed experimentally, as documented in the
literature. Deviations fromaverage vWF ligand size or healthyGPIba-vWF-A1 binding kinetics are observed in simulations to have
signiﬁcant effects on the dynamics of transient platelet aggregation, i.e., the efﬁciency of platelet aggregation and characteristics
of bond failure, in ways that typify diseased conditions. The GPIba-vWF-A1 bond formation rate is predicted to have piecewise
linear dependence on the prevailing ﬂuid shear rate, with a sharp transition in ﬂuid shear dependency at 7200 s1. Interplatelet
bond force-loading is found to be complex and highly nonlinear. These results demonstrate PADas a powerful predictivemodeling
tool for elucidating platelet adhesive phenomena under ﬂow.
INTRODUCTION
Initial platelet tethering to the exposed arterial subendothe-
lium is mediated by the interactions between GPIba platelet
surface receptors and the A1 domain of subendothelial col-
lagen-bound multimeric plasma glycoprotein called von
Willebrand factor (vWF) (1). At moderate to high shear rates
(.500 s1) typical of arteriolar blood ﬂow, GPIba-vWF-A1-
mediated platelet tethering to the subendothelial surface is a
critical requirement for enabling platelet-surface adhesion.
The formation of platelet-surface tethers prolongs the dura-
tion of contact between the platelet and the surface to facil-
itate binding of other, slower-forming, irreversible bonds
such as a2b1 with subendothelial collagen (2,3), and acti-
vated aIIbb3 with collagen-bound vWF (4,5). The GPIba
platelet surface receptor on association with vWF can signal
the binding event to the cell to activate the platelet, thereby
activating other platelet surface receptors such as a2b1 and
aIIbb3 (6–9). GPIba-vWF-A1 bonds exhibit selectinlike
binding kinetics that include fast association and dissociation
rates, dependence of dissociation rate on the magnitude
of tensile or compressive force acting on the bond, and re-
quirement of a critical level of shear ﬂow for adhesion to
occur (10–12). The physiological signiﬁcance of GPIba-
vWF-A1 binding kinetics is illustrated by the genetic
bleeding disorder von Willebrand disease (VWD). This dis-
ease is the result of a gain-of-function mutation in either the
A1 domain of vWF (known as 2B-type VWD) or the GPIba
receptor (known as platelet-type VWD) that alters the bind-
ing kinetics to permit longer bond lifetimes and/or enhanced
bond formation rates (10–15). These increased stabilizing
interactions between the mutant GPIba receptor and vWF
permit sponta neous binding of ﬂowing platelets to circu-
lating vWF, which deplete the availability of vWF, especially
large vWF multimers, for binding to subendothelial compo-
nents during injury. Here, enhanced GPIba-vWF binding
activity manifests as platelet-vWF association in the blood
rather than at the injured surface, the consequence of which is
mild to moderate hemorrhage (16).
vonWillebrand factor multimers are comprised of repeating
identical subunits and exhibit a wide spectrum of molecular
masses (500 KDa, for a vWF dimer, to 20,000 KDa, for ul-
tralarge vWF (ULVWF)) (17–19). Higher-molecular-mass
multimers are found to have an enhanced binding afﬁnity to
platelet surface receptors GPIba and aIIbb3, and greater po-
tency in inducing platelet activation, as well as formation of
platelet aggregates (17,19–24). In the absence of a vascular
injury, ﬂowing platelets interact minimally with circulating
plasma vWF. However, on exposure to abnormally high
shear stresses (.80 dyn/cm2), typical of atherosclerosed re-
gions of the vasculature, platelet GPIba receptors sponta-
neously associate with circulating plasma vWF, causing
platelet activation and aIIbb3-vWF-mediated platelet aggre-
gation and thereby producing platelet thrombi that may have
severe pathological consequences (25–27). Participation of
both GPIba and aIIbb3 is necessary for the formation of
stable shear-induced platelet aggregates (28,29), and vWF is
the only ligand found to be capable of supporting in vitro
platelet aggregation at high shear levels (26).
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Platelets and endothelial cells secrete vWF at the time of
injury. Both cell types secrete the entire gamut of vWF sizes
found in the plasma, and also larger forms than those found in
blood (24). ADAMTS-13, a plasma metalloprotease that
cleaves vWF at the Tyr842-Met843 bond located in the A2
domain, regulates vWF multimer size in plasma (30). Com-
promised activity of this protease or excessive release of
ultralarge forms of vWF from endothelial cells results in
persistence of ULVWF multimers in the blood, causing a
fatal disorder called thrombotic thrombocytopenic purpura
(TTP) (24,31), characterized by thrombocytopenia, hemo-
lytic anemia, shear-induced platelet aggregate formation,
thrombotic occlusions in arterioles and capillaries, and is-
chemic organ damage. At the other end of the spectrum of
vWF-related disorders, mutations causing conformational
changes either in the A2 domain of vWF or in ADAMTS-13
that enhance the rate of proteolytic cleavage of vWF result
in a deﬁciency of high-molecular-weight multimers in the
blood. Association of platelets and vWF is effectively re-
duced in this hemostatic disorder (type-2A VWD) due to
decreased afﬁnity of the shorter vWF multimers for GPIba,
resulting in prolonged bleeding in patients.
This article is Part II of a computational study of the unique
characteristics of hydrodynamic collisions between two
ﬂowing platelet-shaped cells, and the biophysical aspects of
transient aggregation mediated by GPIba-vWF-GPIba bond
bridges. Part I (in this issue) details a comparison of the
collision characteristics of platelet-shaped cells with that of
sphere-shaped cells and also examines the hydrodynamic
effects of the proximity of a planar wall on the collision
trajectories. Detailed quantiﬁcations are obtained that de-
scribe platelet near-wall collision phenomena for use in
platelet adhesive dynamics (PAD) simulations of platelet-
platelet adhesive interactions. The method employed for
deriving platelet binding efﬁciencies for a range of high shear
rates, based on the experimental observations of Huang and
Hellums (32) and Konstantopoulos et al. (29), which are used
for matching PAD simulation predictions of platelet aggre-
gation with experiment, is presented in the ﬁrst article.
In this article, we discuss the development of an adhesive
dynamics model that is employed in a multiscale numerical
simulation method called platelet adhesive dynamics, and we
analyze the transient formation of GPIba-vWF-GPIba bond
bridges between two platelets ﬂowing in linear shear ﬂow near
a ﬂat surface at high shear rates of.4000 s1. The binding of
circulating vWF multimers to platelet GPIba receptors is
modeled as a dynamic process dependent on GPIba-vWF-A1
binding kinetics, and is characterized by a gradual time-de-
pendent redecoration of the platelet surface with vWF mol-
ecules. Platelet aggregation characteristics, as predicted by
the PADmodel for six different high shear rates, are matched
to quantiﬁed platelet aggregation behavior observed experi-
mentally (29,32,33). Platelet aggregation behavior is studied
as a function of the binding kinetics of healthy GPIba-vWF-
A1 bond formation (11) and that typical of platelet-type
VWD (10,14), and also as a function of vWF multimer size.
Useful metrics are quantiﬁed, such as the binding efﬁciency,
number of bonds formed between two platelets in an aggre-
gate, bond rupture forces, bond lifetimes, and bond force-
loading histories, for a range of high shear rates (4500–8000
s1). Implications of vWF multimer size and governing
binding kinetics on the initial phase of high-shear-induced
platelet aggregate formation are explored in this article.
METHODS
The PAD model is a multiscale three-dimensional (3-D) numerical simula-
tion that integrates the adhesive dynamics of receptor-ligand binding with the
3-D hydrodynamic motion of multiple spheroids in shear ﬂow near a sta-
tionary planar surface. The numerical technique employed for calculating the
hydrodynamic mobilities of ﬂowing particles in low Reynolds number ﬂow
near a surface is described in Part I. The general procedure for carrying out
multiplatelet adhesive dynamics simulations is adopted from the multipar-
ticle adhesive dynamicsmethod developed byKing andHammer (34) to study
the inﬂuence of spherical cell-cell hydrodynamic interactions on the selectin-
mediated rolling of leukocytes on a surface, and is described in Part I.
Adhesive dynamics calculations
The general methodology of the adhesive dynamics (AD) algorithm for-
mulated here is derived from the original AD development of Hammer and
Apte (35) and the modiﬁed form of King and Hammer (34). vWF multimers
are treated as virtual molecules, i.e., they are not modeled as separate hy-
drodynamic entities and therefore do not impose or experience a hydrody-
namic force and torque. Binding equilibrium (thermodynamics) governs the
number and extent of ligation of vWFmultimers bound to a platelet cell at the
start of the simulation. The adhesive dynamics model simulates the binding
of two unactivated platelets at high shear rates via GPIba-vWF-GPIba bond
bridges and is detailed in the sections below.
Surface distribution of receptors
Each platelet has 10,688 GPIba receptors distributed uniformly about the
surface, to achieve a surface density of;1500 receptors/mm2 (36) (see Table 1).
A prespeciﬁed number of GPIba receptors ranging from 12 to 54 receptors is
allotted to each surface element of the 384 QUAD9 mesh in accordance with
the area of the element. The GPIba receptor exists as a subunit of the GPIb-
IX-V complex, in which GPIba disulphide linked to GPIbb is noncovalently
associated with GPIX and GPV. Half as many GPV receptors are present on
the platelet surface as GPIb-IX complexes, implying that every GPV receptor
is shared by two GPIb-IX complexes (37). In our model, 5344 random re-
ceptor point locations on the platelet surface are determined at the start of the
simulation, with each point location representing twoGPIb-IX-V complexes,
or two GPIba receptors.
TABLE 1 Values of physical parameters used in simulations
Parameter Deﬁnition Value References
a Platelet radius 1.0 mm (76,77)
l Platelet aspect ratio 0.25 (78)
m Fluid viscosity 1.0 cP —
r Fluid density 1.0 g/cm3 —
ep Platelet surface roughness 50 nm —
s Spring constant 10 pN/nm (52)
T Temperature 298 K —
rreceptor Receptor density 1500 molec/mm
2 (36)
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vWF size and shape
A von Willebrand factor molecule of average size 149 3 77 3 4 nm3 has
;18 A1 binding sites (nine dimers) (38). In the study of Siedlecki et al. (38),
the vWF molecules had already undergone diffusion to a hydrophobic sur-
face followed by adhesion and some spreading.We require the dimensions of
the solution structure of a human vWF molecule of average size. Singh et al.
(39) measured vWF size in solution using light scattering and the small-angle
neutron scattering method, and characterized the vWF multimer as a prolate
ellipsoid of average size 175 3 28 nm. We adopted these dimensions of the
average size of vWF for use in our simulations and assumed that every
multimer contains an average number of 18 A1 binding sites. The surface
area of a prolate spheroid of these dimensions is SA ¼ 0.049 mm2. The av-
erage distance between two A1 binding sites on the surface of this multimeric
molecule is calculated as dvWF-A1 ¼ 52 nm. The other vWF molecule of
interest to us in our interplatelet binding modeling studies is ULVWF, which
is not normally present in blood plasma at detectable levels, except at the time
of secretion from endothelial cells and platelets (4). The physical dimensions
of ULVWF have not been adequately documented in the literature. Slayter
et al. analyzed the size and shape of individual vWF molecules and observed
that vWF multimers are generally found to be present in blood in a range of
sizes up to 460 nm (major axis diameter) and have a loosely coiled ellipsoidal
shape (40). We chose to model a large vWF molecule (L-vWF) of dimen-
sions 4003 28 nm (SA ¼ 0.11 mm2). Since L-vWF and ULVWF have been
described as stringy threadlike molecules (40,41), we assumed that the
thickness of the molecule remains approximately the same with an increase
in molecular mass such that most of the A1 binding sites are available for
association at the surface rather than being hidden within the interior of the
protein. L-vWF is assumed to possess 34 A1 sites available on the surface for
binding, so that dL-vWF-A1 is within 10% of dvWF-A1. The average distance
between two A1 binding sites on this molecule is dL-vWF-A1 ¼ 57 nm.
vWF concentration in plasma
Differing concentrations of vWF in plasma have been reported in the liter-
ature (21,38,42–45). If plasma vWF molecules contain, on average, 18 A1
binding sites (i.e., 9 vWF dimers), then the average molecular mass of a
vWF multimer is 260 kD per subunit 3 18 subunits ¼ 4680 kD ¼ 4680 3
103 g/mol. The vWF plasma concentration for an average vWF size of
18-mers is determined to be 2 nM based onmolar and/or mass concentrations
of vWF in plasma, as reported by Miura et al. (43), Kumar et al. (21), and
Borchiellini et al. (45). A sample calculation is shown here. Kumar et al.
reported the concentration of vWF in normal pooled plasma as 10mg/ml. The
molar concentration of vWF is calculated as
0:01 g=L
46803103g=mol ¼ 2:1 nM:
vWF binding properties
The two following vWF sizes are considered in our simulations.
n-vWF (vWF multimers of average size (diameter along major axis ¼
175 nm)). In our model, vWF molecules can attach lengthwise to the
platelet surface and bind multiple receptors. It is assumed that up to one-half
of the total A1 binding domains present on the surface of a vWF multimeric
molecule can bind a single platelet. The average platelet surface area per
receptor point location, also termed ‘‘receptor node’’ (distinct from the nodes
generated by the 384 QUAD9 mesh used to discretize the platelet surface), is
calculated as 1332 nm2. The average distance between two receptor nodes is
36.5 nm. The maximum number of receptor nodes that an n-vWF molecule
can bind is based on the length of the multimer and is calculated as 175/36.5
4. An n-vWF molecule that docks onto a platelet surface is allotted a unique
invariant group of four receptor nodes chosen in random fashion such that
within each group, the receptor nodes are within a distance of 175 nm/1.5
from the ﬁrst randomly chosen node in the group and also within the same
distance from all other nodes in the same group. Binding of A1 sites on a
vWFmolecule can occur with receptors located at the allotted point locations
only. The total GPIba-vWF-GPIba bond length is calculated to be 50 nm1
28 nm1 50 nm¼ 128 nm, where 50 nm is the length of the GPIba stalk (46).
L-vWF (vWF multimers of large size (diameter along major axis ¼ 400
nm). The maximum number of receptor nodes on a platelet that a single
L-vWF molecule can bind is 400/36.5 10. A unique group of 10 randomly
chosen receptor nodes is assigned to every L-vWF molecule that binds the
platelet surface.
Platelet-vWF equilibrium binding
Each simulation is initiated with one of the two platelets bound by vWF
molecules; the number and extent of ligation of the vWF multimers are
dictated by the binding equilibrium of this receptor-ligand pair. We used the
equivalent site hypothesis (ESH) equilibrium model (47) for multivalent
ligand binding to monovalent receptors to determine the vWF distribution on
the platelet surface at equilibrium. In this model, the two-dimensional cross-
linking rate constants for both the forward and reverse reaction are assumed
to be the same for all ligand binding sites, once the ligand has docked onto the
surface via a single initial GPIba-vWF-A1 bond. The equilibrium concen-
tration of ligand (number of ligands/cell) bound by i receptor-ligand bonds is
given by Eq. 1,
Ci;eq ¼ f !
i!ðf  iÞ!
 
Ki1x
v
f
Lo
KD
 
Rieq; (1)
where v is the total number of A1 binding sites present on the vWF surface;
f is the total number of A1 binding sites available for binding to a single
platelet; Kx is the two-dimensional cross-linking equilibrium constant (cells/
number); Lo is the ligand concentration in solution (M), and is assumed to
change negligibly during ligand-cell binding; KD is the three-dimensional
dissociation constant for solution vWF bound to platelets via a single GPIba-
vWF-A1 bond (M); and Req is the equilibrium concentration of unbound
receptors present on the cell surface (number of receptors/cell), which can be
determined from the following implicit equation:
RT ¼ Req 11 v Lo
KD
 
ð11KxReqÞf1
 
; (2)
where RT is the total number of GPIba receptors present on the platelet
surface.
The procedure followed to obtain a suitable KD value representative of
shear-induced platelet GPIba-vWF binding in solution for use in the ESH
equilibrium binding model is discussed in Appendix A. The derived value of
KD based on the experimental studies of Goto et al. (28) is 7.73 3 10
5 M.
This value of KD yields Req ¼ 10,472 and Ceq,1 ¼ 5; Ceq,2 ¼ 12; Ceq,3 ¼ 17;
Ceq,4 ¼ 15; Ceq,5 ¼ 9; Ceq,6 ¼ 4; Ceq,7 ¼ 1; Ceq,8 ¼ 0; Ceq,9 ¼ 0, for equi-
librium binding of n-vWF to platelets, which results in a 2% platelet surface
coverage of vWF based on this equilibrium dissociation constant.Miura et al.
(43) predict a platelet surface coverage by vWF of 1.2% based on their
measured KD values. If L changes negligibly after binding, i.e., if L  nC/
NAV, where C is the total number/cell of bound vWFmolecules given by Eq.
1, n is the volume concentration of platelet cells in blood (2.75 3 1011
platelet cells/L) and NAV is Avogadro’s number, then Eq. 1 applies. The
binding of vWF to platelets as predicted by the ESH model results in a de-
pletion of vWF molecules by only 1.4%, verifying the validity of Eq. 1.
Accordingly, the calculated KD value of 7.73 3 10
5 M is used for further
model development. The equilibrium binding conditions for two patholog-
ical cases of vWF-platelet binding (L-vWF-mediated binding (TTP) and
platelet-type VWD) as predicted by the ESH model are discussed in Ap-
pendix B.
Model rules and assumptions governing binding
1. Two vWF molecules cannot bind to the same receptor nodes for reasons
of steric blocking (Rule 1). In case a vWF molecule attempts to bind
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very close to another docked vWF molecule on the platelet surface (i.e.,
tries to bind receptors at one or more common receptor nodal positions)
the molecule will be prevented from docking onto the cell.
2. Receptors at nodes where a vWF molecule is positioned are the only
receptors on that platelet that can bind that molecule (Rule 2), i.e., a
vWF multimer that has docked onto the surface of a platelet is immobile
and does not reorient itself with respect to the surface.
3. Receptors from a maximum of 4 (or 10) receptor nodes depending on
the vWF molecule size present on a platelet surface can bind a vWF
molecule (Rule 3).
4. If a vWF molecule is positioned at a receptor node, the receptors located
at that receptor node cannot participate in receptor-ligand binding to any
other vWF molecule (steric blocking) whether located on the same
platelet or on a second platelet (Rule 4).
5. A vWF molecule bound to a single platelet is always assumed to have
its A1 binding sites positioned optimally close to the receptors at
neighboring receptor nodes (with negligible deviation from equilibrium
bond length) such that the cross-linking forward rate constant is the only
parameter required to describe the forward binding rate (Rule 5).
Dynamics of platelet binding to soluble vWF
Formation of GPIba-vWF bonds. The procedure followed to calculate
the on-rate, kon, for single bond association between platelet GPIba and
circulating vWF is discussed in Appendix C. Bond formation and dissoci-
ation is tested using probability formulations Pf (probability of forward re-
action) and Pr (probability of reverse reaction), described in Hammer and
Apte (35),
Pf ¼ 1 expðkfDtÞ;
Pr ¼ 1 expðkrDtÞ; (3)
where kf and kr are given in s
1 units and Dt is the simulation time step.
Monte Carlo simulations are performed to test for the formation of new bonds
between 1), platelet surface receptors and bound vWF molecules positioned
at the corresponding receptor nodes (here, kf is given by the two-dimensional
(2-D) cross-linking forward rate constant, k0f;2D; which has not been
measured experimentally and is assumed to be the same as that for cross-
linking of a vWF molecule by two different platelets (48)); and 2), receptors
on a platelet and vWF molecules in solution at receptor nodes not occupied
by a vWF molecule or whose receptors are not bound to vWF molecules on
other platelets (Rules 1 and 4) (here, kf ¼ konL) (see Table 2). Amaximum of
1:1+i¼f
i¼1 Ci;eq vWF molecules are allowed to bind a platelet cell at one time.
Dissociation of GPIba-vWF bonds. Shankaran et al. (49) estimated
the shear force acting on a GPIba-vWF complex in linear shear ﬂow at 9600
s1 to be of magnitude 1.5 pN (m¼ 1.1 cP). In their study, vWFwas modeled
as a sphere of diameter 70 nm and the GPIba receptor as a thread of 55 nm
length extending from a spherical platelet of 2.04 mm diameter. Our model
considers cell geometry or shape that is physiologically relevant, and is
therefore different from that used in the study of Shankaran et al. (49). To
accurately calculate the stresses acting on the bond, the vWF particle must be
modeled as a ﬁnite-sized prolate spheroid. Shear force and torque are com-
plex functions of the three-dimensional orientation of the particle. The actual
force and torque acting on the vWF particles is not determinable from our
simulation model since the vWF particles are modeled as virtual ﬁnite-sized
particles. We used the estimate by Shankaran et al. of 1.5 pN as an ap-
proximation of the shear forces acting on a vWF particle bound to the platelet
surface. The reverse rate constant is calculated using the Bell model for force-
dependent dissociation rate of weak noncovalent bonds:
kr ¼ k0r exp
gFb
kBT
 
; (4)
where kr(Fb) is the bond dissociation rate, k
0
r is the unstressed off-rate, g is the
reactive compliance, Fb is the applied force on the bond, and kBT is the
product of Boltzmann constant and temperature (50). The Bell model
parameters (k0r ¼ 5:47 s1; g ¼ 0.71 nm) used in this study for GPIba-
vWF dissociation kinetics were obtained from optical tweezer studies
conducted by Arya et al. (11). The hydrodynamic shear force exerted on a
bound vWF ligand is assumed to be shared equally by all bonds formed
between a single platelet and the vWF multimer. Thus, the bond force Fb in
Eq. 4 is given by
ð1:5 pNÞ
nb
; where nb is the total number of bonds formed
between a vWF multimer and a platelet, and varies during the course of the
simulation for each bound ligand. Bonds may break at any receptor node at
which a vWF is bound. If all bonds between a vWF molecule and a platelet
break, the molecule goes back into solution.
Platelet-platelet binding
Receptors located at one or more receptor nodes on a platelet can bind the A1
domain binding sites present on vWF multimers attached to another platelet
in close vicinity. When two platelets come within binding distance (as dic-
tated by the equilibrium bond length of GPIba-vWF-GPIba) to each other,
binding of free GPIba receptors on one platelet in close proximity to a vWF
molecule bound to the opposing platelet’s surface is tested using Eq. 3. All
GPIba-vWF-A1 bonds involved in the bridging of two platelet cells are
treated as individual linear springs (Fig. 1). The mathematical relation for the
rate of bond formation was obtained using Bell et al.’s (51) derived ex-
pression for the equilibrium constant for cell-cell bond bridging (34). The
dependence of bond formation rate constant kf on the deviation bond length
jxb  lbj is described by Eq. 5,
kf ¼ k0f;2Dexp sjxb  lbj
g  0:5jxb  lbj
kbT
 
; (5)
where k0f;2D is the intrinsic cross-linking formation rate constant, s is the
spring constant, lb is the equilibrium bond length, xb is the distance spanning
the endpoints of the GPIba receptor on the platelet surface and the vWF-A1
binding site, and g is the reactive compliance of the bond. The two-
dimensional cross-linking forward rate constant k0f;2D has not been well
determined experimentally and is the single adjustable parameter in this
model. The rate of formation, as well as the dissociation rate of interplatelet
bonds, is calculated based on the following assumptions:
TABLE 2 Values of binding kinetic parameters used in simulations
Parameter Deﬁnition L-vWF n-vWF platelet-type VWD References
lb (nm) Equilibrium GPIba-vWF-GPIba
bond length
128 128 128 (39,46)
KD (M) 3-D dissociation constant 7.73 3 10
5 7.73 3 105 1.55 3 105 (28)
konL (s
1) 3-D intrinsic on-rate 1.38 3 104 1.22 3 104 1.39 3 104 —
k0f;2D (s
1) 2-D cross-linking intrinsic on-rate Determined by matching
simulation results
with experiment
Same as for L-vWF Same as for L-vWF —
kor (s
1) Intrinsic off-rate 5.47 5.47 5.47/5 (11,14,43)
g (nm) reactive compliance 0.71 0.71 0.71 (18)
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1. When a platelet-bound vWF multimer is within binding distance of
another platelet, or if the vWF multimer is double-bound by two
opposing receptor nodes on the bridged platelets, the vWF molecule is
assumed to be equidistant from the two receptor nodes on either platelet
surface that are either in close vicinity or, if additional bonds are being
tested, already linked by the bridging vWF molecule.
2. The two GPIba-vWF-A1 bonds that form a trimolecular GPIba-vWF-
GPIba bond linking two platelets are always stressed equally.
3. The two GPIba-vWF-A1 bonds that form a trimolecular GPIba-vWF-
GPIba bond are oriented in the direction of the vector joining the two
receptor nodal points located on either platelet surface that deﬁne the
endpoints of the trimolecular bond.
If a bond spring deviates from its equilibrium length, the bond imposes an
instantaneous force and torque on the bridged cells that is a function of the
deviation bond length and orientation of the stretched or compressed bond
with respect to the participating bound surfaces (spring constant s ¼ 10 pN/
nm (52)). Bonds can break between bound A1 sites on a vWF molecule and
either platelet’s receptors. The bond length used for determining the bond
force, and therefore the bond dissociation rate constant (Eq. 4, where Fb¼ s
jxb – lbj and 2lb¼ 0.128 mm) for each platelet’s receptor-ligand bond, is half
the total distance between the linked receptor nodes on either platelet. When
two platelets bind a vWF molecule and all bonds break between a vWF
molecule and one of the two platelets, then the vWFmolecule transfers to the
other platelet. A critical assumption made is that the stressing of bonds be-
tween receptors and a vWF multimer only occurs at the receptor nodes
participating in interplatelet binding. These stresses are not transmitted to
adjacent receptor nodes where the vWFmolecule may be bound. We assume
that vWF is a ﬂexible and linear molecule that absorbs the stresses at the point
of action and does not transmit them along its length (a common assumption
made with the cell surface) (Rule 6).
Receptor and ligand populations
It is assumed that all GPIba receptors form a single population of active
receptors and all A1 domains of vWF molecules are in an active ‘‘bindable’’
state. We did not consider a subpopulation of molecules that exist in or
switch to a dormant or nonbinding state. Insufﬁcient quantiﬁcations of such
phenomena in the literature preclude the development of a more sophisti-
cated model at this time.
RESULTS
Estimation of k 0f;2D; matching simulation
predictions to published experimental results
(L-vWF-mediated platelet-platelet binding)
The single unknown parameter in the PAD model for plate-
let-platelet transient aggregation in high shear ﬂow is the 2-D
cross-linking intrinsic bond formation rate constant k0f;2D: A
randomized search was performed to obtain k0f;2D values that
permit simulation predictions of the binding efﬁciency hb for
collisions between an L-vWF1 platelet and an L-vWF
platelet at a particular shear rate to match, to within 5%,
experimentally derived values (29,32,33) tabulated in Table
1 of Part 1. Huang and Hellums obtained the experimentally
derived overall collision efﬁciencies, hc (32,33) (see Part I,
Table 1) of platelets aggregating at high shear rates by de-
termining parameters that matched a theoretical population
balance rate equation (33) (see Part I) to the experimental
observations of particle size distributions of platelet aggre-
gates produced by shear-induced platelet aggregation. A
cone-and-plate viscometer apparatus was used to subject
unactivated platelets (concentration ;300,000 platelets/mL)
to a uniform high-shear environment (;3200–10,000 s1)
over durations of 20–100 s at either 24C or 37C. The width
of the gap between the cone and plate ranged from 30 mm at
the inner edge to 120 mm at the outer edge. Their experi-
mental study of platelet aggregation involved a majority of
far-wall platelet collisions; however, our simulation model
was developed to consider physiologically relevant situations
such as platelet adhesion events close to the vascular wall.
Hence, we studied wall effects on platelet adhesion events,
since proximity to the wall signiﬁcantly inﬂuences the col-
lision mechanics (time integral of contact area and collision
frequency) and collision and adhesion parameters were de-
termined accordingly.
The binding efﬁciency is a quantitative measure of the
probability of formation of at least one cell-cell bond bridge
between two colliding cell surfaces. Three representative
initial collision conﬁgurations (collision types I–III, deter-
mined in Part I) were selected to characterize the entire range
of homogeneous hydrodynamic platelet collisions observed
near a planar surface. To obtain the model-predicted overall
binding efﬁciency for two colliding platelets for an assumed
k0f;2D value at a particular shear rate, the binding efﬁciency,
characteristic of each collision type, was ﬁrst determined. For
each of the six shear rates, and for every k0f;2D tested, at least
100 simulations of two-platelet collisions were conducted for
each of the three representative initial collision conﬁgura-
tions. The total number of collisions that resulted in a binding
event (formation of a GPIba-vWF-GPIba bond bridge) es-
FIGURE 1 Schematic diagram of the platelet-platelet
bridging model that depicts two platelets transiently aggre-
gating in linear shear ﬂow via GPIba-vWF-GPIba bond
formation. A single vWF molecule can bind several recep-
tors on a single platelet. Each platelet is coated with a
50-nm incompressible surface roughness layer equal to the
height of the GPIba surface receptors. Components of the
diagram are not drawn to scale.
2560 Mody and King
Biophysical Journal 95(5) 2556–2574
tablished the efﬁciency of binding for that collision type. A
weighted average of the binding efﬁciencies obtained for
each of the three collision types provided the overall binding
efﬁciency observed for two platelets (one L-vWF1 platelet
and one L-vWF platelet) for the assumed k0f;2D at the
imposed ﬂuid shear rate. The weights used for the averaging
were linearly proportional to the number of near-wall colli-
sions out of a total of 85 distinct observed collisions that each
collision type represented. The weights were determined to
be 0.488, 0.182, and 0.330 for collision types I–III, respec-
tively.
Fig. 2 A is a plot, based on simulation results, of the the-
oretically predicted binding efﬁciency between two colliding
platelets for each of the three collision types, at an imposed
ﬂuid shear rate of 8000 s1 for four different k0f;2D values.
The error bars depicted in Fig. 2 A denote the standard error
of the mean, which was determined using the bootstrap
method (53). The overall binding efﬁciency, which is cal-
culated based on the individual efﬁciencies for each repre-
sentative collision type, is shown in Fig. 2 B. The model-
predicted binding efﬁciency of 0.247 at k0f;2D ¼ 4.0 is within
5% of the experimentally derived value of 0.236 (29,32,33),
also shown in Fig. 2 B. The k0f;2D values that produce a good
match between the theoretically predicted overall two-
platelet binding efﬁciencies and the experimentally deter-
mined platelet binding efﬁciency (29,32,33) for all six dif-
ferent shear rates are listed in Table 3. k0f;2D values listed in
Table 3 for shear rates 4500, 5400, 6300, 7200, and 8000 s1
have been estimated using linear interpolation (between
k0f;2D ¼ 0:3 and 0.4 for g ¼ 4500 s1; between k0f;2D ¼ 0:5
and 0.6 for g ¼ 5400 s1; between k0f;2D ¼ 1:0 and 1.2 for
g¼ 6300 s1; between k0f;2D ¼ 1:2 and 1.5 for g¼ 7200 s1;
and between k0f;2D ¼ 3:0 and 4.0 for g ¼ 8000 s1; see
Table 4 for binding efﬁciency values over which interpola-
tions were performed), to obtain a better estimate of k0f;2D
that provides a closer match to the desired binding efﬁciency.
Overall platelet binding efﬁciencies, hb, as observed from
our simulations at ﬂuid shear rates of 4500, 5400, 6300, and
7200 for a select range of assumed k0f;2D values are tabulated
in Table 4. As expected, efﬁciency in platelet-platelet binding
is observed to improve consistently with increase in the
magnitude of k0f;2D at any given shear rate.
The binding properties of the GPIba-vWF-A1 bond that
mediates platelet attachment to the surface and platelet-
platelet aggregation, is modulated by the local ﬂuid shear
stress. In these simulations, k0f;2D is the only kinetic pa-
rameter that incorporates the effects of the shear level in the
ﬂuid on the association properties of the GPIba-vWF-A1
bond. The effective dissociation rate constant is a function of
the bond force; the compressive or tensile force that acts on
the GPIba-vWF-A1 bond formed between two ﬂowing
platelets results from the relative translation and rotation
of one platelet with respect to the other platelet and
is primarily a function of the shear ﬂow ﬁeld as well as
the shear rate. The estimated k0f;2D values that provide a
good match between simulated and experimentally obtained
values (29,32,33) of the two-platelet binding efﬁciency for
six different ﬂuid shear rates are plotted in Fig. 3 as a func-
tion of shear rate. An exponential function, k0f;2D ¼
0:0165e0:00065g; was ﬁtted using the linear least-squares re-
gression technique to the six k0f;2D data points, with an av-
erage absolute error of 0.1807. A piecewise linear curve,
k0f;2D ¼ 0:00042g  1:601; g# 7200s
1
0:00269g  18:063; g$ 7200s1 ;

was also ﬁt-
ted using the linear least-squares regression technique to the
six k0f;2D data points with an average absolute error of
FIGURE 2 Predictedbindingefﬁciency
for collisions between anL-vWF1 plate-
let and an L-vWF–platelet at an imposed
ﬂuid shear rate of 8000 s1. (A) Binding
efﬁciencies characteristic of the three
representative collision types plotted for
four different k0f;2D values.One hundred
two-platelet collisionswere simulated for
each of the three representative collision
types. (B) Overall binding efﬁciency cal-
culated as a weighted average of the
binding efﬁciencies determined for the
three representative collision types for
four different k0f;2D values. Error bars
indicate mean6 SE.
TABLE 3 2-D cross-linking forward rate constant k 0f;2D for six
different shear rates that permit a good match between
theoretically predicted and experimentally derived platelet
binding efﬁciencies
Shear
rate
g (s1)
Binding efﬁciency
hb (L-vWF) Derived
from experiment
Binding efﬁciency
hb (L-vWF) Predicted
by simulations
k0f;2D
(s1)
4500 0.041 0.041 0.33
5400 0.047 0.047 0.53
6300 0.091 0.090 1.06
7200 0.105 0.106 1.40
7700 0.191 0.184 2.50
8000 0.236 0.236 3.60
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0.0836. The predicted k0f;2D values appear to be consistent
with a piecewise linear model of the dependence on the im-
posed ﬂuid shear rate.
Predicted platelet binding efﬁciencies for
n-vWF-mediated platelet aggregation and
platelet-type VWD
The estimated k0f;2D values tabulated in Table 3 provide a
measure of the ability of a free GPIba receptor present on a
freely ﬂowing platelet to bind a vWFmultimer already bound
to the surface of the same or another freely-ﬂowing platelet.
The sharp increase in k0f;2D values at high shear rates of
;8000 s1 indicates a sharp transition of the receptor-ligand
binding properties from a poorly binding, or unresponsive,
state to an aggressive-binding, or responsive, state. The ﬂuid
shear stress appears to be instrumental in turning on a bio-
mechanical switch to promote receptor-ligand association.
The k0f;2D estimates were applied to two other cases of
platelet-platelet binding in high shear ﬂows. 1), n-vWF-
mediated platelet-platelet binding in solution; and 2), n-vWF-
mediated platelet-platelet binding in solution, in which
GPIba receptors possess a gain-of-function mutation that
produces the phenotype commonly known as platelet-type
von Willebrand disease (VWD). The two-platelet binding
efﬁciency for these two additional cases was determined at
three different shear rates: 4500 s1, 6300 s1, and 8000 s1.
A comparison of the binding efﬁciencies obtained from sim-
ulations for the three cases—L-vWF, n-vWF, and n-vWF 1
platelet-type VWD—is presented in Fig. 4.
As predicted by our simulations, platelets that undergo
collisions under normal conditions, in which n-vWF is pre-
sent in solution, do not form any interplatelet bonds at shear
rates 4500 s1 and 6300 s1. This is in good agreement with
the experimental observations of the occurrence of detect-
able vWF-mediated shear-induced platelet aggregation only
at ﬂuid shear stresses of 80 dyn/cm2 and higher (26,49).
Binding efﬁciencies determined for n-vWF-mediated bind-
ing of two platelets are signiﬁcantly different from the
binding efﬁciencies observed for L-vWF-mediated platelet
binding and binding under conditions of platelet-type VWD
(unpaired Student’s t-test, p , 0.001). Binding efﬁciencies
for n-vWF-mediated binding of two platelets inclusive of
platelet-type VWD binding kinetics for the three different
shear rates are found to be different from that for L-vWF-
TABLE 4 Observed platelet binding efﬁciencies based on PAD simulations for four different shear rates and a select range of
assumed k 0f;2D values
g ¼ 4500 s1 g ¼ 5400 s1 g ¼ 6300 s1 g ¼ 7200 s1
k0f;2D s
1 hb k0f;2D s
1 hb k0f;2D s
1 hb k0f;2D s
1 hb
0.3 0.0357 0.5 0.0427 1.0 0.0745 1.2 0.0891
0.4 0.0526 0.6 0.0573 1.1 0.1007 1.5 0.1138
0.6 0.0684 0.7 0.0663 1.2 0.1105 1.8 0.1395
FIGURE 3 Plot of the estimated 2-D cross-linking forward rate constant
k0f;2D as a function of ﬂuid shear rate obtained from matching simulation
predictions to experimentally quantiﬁed binding efﬁciencies (29,32,33). An
increasing exponential function and a piecewise linear function are ﬁtted to six
data points.
FIGURE 4 Bar graph showing a comparison of the simulated two-platelet
binding efﬁciencies for three different aggregation scenarios at three differ-
ent high shear rates. Error bars indicate mean 6 SE.
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mediated binding. Note that the receptor occupancy at
equilibrium is twofold greater in the case of platelet-type
VWD than in the case of L-vWF-mediated aggregation.
Binding efﬁciency is a function of receptor distribution on the
platelet surface, ligand distribution on the platelet surface, the
cross-linking forward rate constant, and the hydrodynamic
characteristics of platelet collisions, i.e., the time integral of
contact area and separation distance of surfaces during col-
lision. The predicted binding efﬁciencies at a particular shear
rate vary, as shown in Fig. 4 for the three different binding
scenarios, as a result of the dissimilar extents of vWF dis-
tribution on one of the two colliding platelet surfaces, which
in turn is dependent on vWF multimer size and the binding
kinetics of the GPIba-vWF-A1 bond.
Effects of Interplatelet bond formation on
platelet-platelet collision properties
The formation of GPIba-vWF-GPIba bond bridges between
two colliding platelets in shear ﬂow is expected to alter the
contact time during the collisions and therefore the duration
over which the platelet surfaces remain in reactive contact.
The formation of transient interplatelet bonds facilitates the
formation of slower-forming permanent bonds such as acti-
vated integrins with their respective ligands that mediate the
formation of stable platelet aggregates. The time integral of
the contact area ATI (deﬁned in Part I) was determined for
all platelet collisions that resulted in interplatelet binding at
the imposed ﬂuid shear rate of 8000 s1, and was compared
to the ATI characteristic of nonreactive collisions. Table 5
tabulates the average percentage enhancement in ATI as
a result of interplatelet bond formation for two platelet-
platelet binding scenarios: 1), L-vWF, and 2), platelet-type
VWD.
On average, at a high shear rate of 8000 s1, the formation
of interplatelet bonds is observed to only marginally increase
the intimacy of the cell-cell contact during a collision. As
seen in Table 5, there is considerable variability in the effects
of interplatelet bridging on the contacting properties of the
bridged platelets. Interplatelet binding can result in a de-
crease in the time-integral of contact area, i.e., platelet
bridging can reduce the extent of contact that normally occurs
between two platelets in the absence of any reaction. The
formation and rupture of bonds alter the original collision
trajectories (usually slightly, but occasionally dramatically),
although not necessarily the mechanism of collision. The
extent of modiﬁcation of the original paths depends on the
location of the bonds formed with respect to each surface,
the number of bonds formed, and the strength and lifetime of
each bond formed. The new collision paths can occasionally
result in decreased contact between the cells. If two or more
bonds are formed, the alteration in collision trajectories that
may lead to a lower time integral of contact area is often
outweighed by the increase in contact time due to the restraint
created by the bonds. Out of the 202 total successful colli-
sions included in Table 5, 160, 37, and 5 involved the for-
mation of one, two, and three bond bridges, respectively,
between the two platelets. Of the 160 single-bond aggrega-
tion events, 69% had greater ATI than the nonreactive case. Of
the 37 double-bond aggregation events, 81% involved an
increase in ATI. All triple-bond aggregation events experi-
enced greater cell-cell contact during a collision compared to
the nonreactive collision event.
Characteristics of GPIba-vWF-A1 bonds that
mediate platelet-platelet binding
Characteristic binding properties such as bond lifetimes,
bond rupture forces, and number of bond bridges that formed
between two colliding platelet surfaces were quantiﬁed at an
imposed ﬂuid shear rate of 8000 s1 for two binding sce-
narios: 1), L-vWF-mediated aggregation, and 2), n-vWF-
mediated aggregation with platelet-type VWD. The average
lifetime of a bond that bridges two colliding platelets at a ﬂuid
shear rate of 8000 s1 and the average bond force at the time
of rupture are plotted in Fig. 5, A and B, for the three repre-
sentative collisions (types I–III) and for both L-vWF and
VWD binding scenarios. A weighted average of the bond
lifetime and the bond rupture force for the three representa-
tive collisions provides overall average values of the bond
characteristics for each of the two binding scenarios, which
are also plotted in Fig. 5, A and B. The average number of
interplatelet bonds that formed during a single successful
collision (a successful collision is one that results in at least
TABLE 5 Change in collision properties due to interplatelet binding for the case of L-vWF-mediated platelet aggregation and
(n-vWF 1 platelet-type VWD)-mediated platelet aggregation
L-vWF Platelet-type VWD
Shear
rate,g (s1)
Collision
type
Avg. % change
in ATI
Max. %
increase in ATI
Max. %
decrease in ATI
Avg. %
change in ATI
Max. % increase
in ATI
Max. %
decrease in ATI
8000 I 0.99 9.75 6.05 5.00 24.11 15.05
8000 II 2.25 11.48 1.64 5.86 40.70 3.38
8000 III 1.32 20.44 3.21 1.52 8.43 31.18
For L-vWF collision types I–III, n ¼ 30, 35, and 35, respectively; for VWD collision types I–III, n ¼ 38, 35, and 29, respectively, where n is the number of
successful collisions.
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one binding event) is plotted for each of the three represen-
tative collisions and also for the overall case in Fig. 5 C.
The difference between the binding kinetics of L-vWF-
mediated platelet aggregation and n-vWF-mediated platelet
aggregation governed by platelet-type VWD binding kinetics
is the ﬁvefold-smaller dissociation rate constant for the latter
case (see Table 2). As a result, larger average GPIba-vWF-A1
bond rupture forces and bond lifetimes are observed for the
case of platelet-type VWD (includes gain-of-function muta-
tion in the receptor binding domain) as compared to that for
L-vWF-mediated binding (lacking the gain-of-function mu-
tation). Average bond rupture forces for L-vWF-mediated
binding and platelet-type VWD are signiﬁcantly different for
all three representative collision types (p, 0.005 for all three
cases, unpaired one-tailed Student’s t-test). The overall aver-
age bond lifetimes for L-vWF-mediated binding and platelet-
type VWD are also found to be signiﬁcantly different (p ,
0.05). In Fig. 5, the overall average bond lifetimes for the two
cases differ by 4.2 ms. The difference in the overall average
bond rupture forces for the two cases is 10.4 pN. Clearer
insight into these quantitative results can be gained by
studying the force-loading diagrams that are plotted in Figs. 6
and 7, and which are discussed below. Note that the binding
characteristics—average bond lifetime and average bond
rupture force—are expected to be the same for both L-vWF-
mediated platelet aggregation and n-vWF-mediated platelet
aggregation, since the dissociation kinetic parameters are the
same in both cases.
The average number of bonds that form between two
colliding platelets is slightly different for platelet binding
governed by platelet-type VWD binding kinetics and
L-vWF-mediated platelet binding. The number of A1 do-
mains of the platelet-surface bound vWFmultimers available
for binding to another platelet in the platelet-type VWD case
(10,881 A1 domains (12093 9)) at equilibrium conditions is
greater than that for the L-vWF case (7548 domains (444 3
17)) by 44%. The greater availability of ligand binding do-
mains on the platelet surface in the former case appears to
have a minor inﬂuence on enhancement of platelet aggre-
gation in comparison to L-vWF-mediated binding, and this is
also suggested by the binding efﬁciencies depicted in Fig. 4.
Out of the 43 collisions that resulted in two or more binding
events, 14% of such collisions involved two or more bonds
coexisting for a ﬁnite period of time. Thus, the majority of
binding events occurred independently of each other during
platelet collisions, i.e., the next bond bridge formed only after
the previous bond bridge broke.
As is evident from Fig. 5 A, larger average bond lifetimes
coincided with greater duration of contact between the two
colliding platelet surfaces during a collision. Platelet colli-
sions are generally characterized by a relative sliding motion
between the two colliding platelet surfaces, as demonstrated
in Part I. Although short collisions involve quick sliding of
one platelet surface over the second surface, collisions that
are longer-lived involve collision trajectories that permit the
local contacting platelet surfaces to be relatively stationary
with respect to each other for part of the duration of the
collision. This allows some of the interplatelet bonds formed
during a collision of longer duration to experience relatively
mild stresses for a longer time in comparison to the case of
shorter-lived collisions. The average number of interplatelet
bonds that form during a collision is also observed to increase
modestly with increase in the collision duration. The maxi-
mum number of interplatelet bonds that formed during any
collision was three. The GPIba-vWF-A1 bond character-
istics—i.e., bond lifetimes, bond rupture forces, and bond
number—for the two binding scenarios (L-vWF-mediated
binding and platelet-type VWD) at a ﬂuid shear rate of 6300
s1 are qualitatively similar in all respects to the binding
characteristics depicted in Fig. 5 for a shear rate of 8000 s1
(data not shown). Characterization of binding properties at
lower shear rates was not feasible due to the scarcity of bond
formation events, which made it difﬁcult to determine aver-
age properties.
Bond force-loading histories
Platelet-platelet bond bridges were found to primarily break
under tension, and barring only three rupture events, the re-
maining 246 bond breakage events that occurred at a shear
rate of 8000 s1 resulted from tensile failure. Fig. 6 plots the
FIGURE 5 Binding characteristics of the GPIba-vWF-A1 bond that
bridges two colliding platelets at a ﬂuid shear rate of 8000 s1 for two
binding scenarios 1), L-vWF, and 2), platelet-type VWD. (A–C) The average
bond lifetimes, average bond rupture forces, and average number of
interplatelet bonds, respectively, formed during a successful collision, are
plotted for the three representative collision types and the overall weighted
case for both binding scenarios. Numbers of binding events, n, are 33, 42,
and 46 for collision types I–III, respectively, in the case of L-vWF-mediated
binding; and 45, 43, and 40 for collision types I–III, respectively, in the case
of binding typical of platelet-type VWD. Error bars indicate mean 6 SE.
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bond force-loading histories for six representative platelet-
platelet bond bridges that formed during type I collisions and
type III collisions for the case of L-vWF-mediated platelet
aggregation. Note that type III collisions have a time integral
of contact area that is threefold larger than that of type I
collisions. The bond force histories for type II collisions were
found to have a nature intermediate to that of types I and III
(data not shown). Figs. 5 A, 6, A and B, and 7, A and B, show
that bonds are more long-lived when formed during a type III
collision than when formed during a type I collision. The
force-loading on the bond is highly nonlinear and the bond
forces are found to switch from compressive stress to tensile
stress, with failure almost always occurring under tension.
The bonds break under a high rate of increasing tensile force.
Fig. 6, C and D, depicts the tensile force ramp that is exerted
on each bridging bond over the last 10 pN of the life of the
bonds before rupture. In Fig. 6,C andD, the time has been set
to 0 s for those data points in the bond force history curves
shown in Fig. 6, A and B, that correspond to 10 pN less than
the bond rupture force. The bridging bonds at the time of
rupture are found to experience a linear force ramp of 8.1 pN/
ms on average (SD ¼ 1.82) for the six binding events shown
in Fig. 6 C, and 5.9 pN/ms on average (SD¼ 2.89) for the six
binding events shown in Fig. 6 D. The conditions of bond
breakage for collision type I appear more uniform compared
to the conditions prevailing at the time of bond rupture for
collision type III. In Fig. 6 C, the slope of each plotted force
history curve and the slope of the ﬁrst half of each curve has
,2% difference, demonstrating the linearity of the force
ramp that exists at the time of rupture. In Fig. 6D, the slope of
each plotted force history curve and the slope of the ﬁrst half
of each curve has ,5% difference in all cases except one
(14% difference).
In a similar way, plots of the bond force-loading histories
for the case of n-vWF-mediated platelet binding governed by
platelet-type VWD binding kinetics are presented in Fig. 7.
As depicted in Fig. 7 A, the six representative GPIba-vWF-
A1 bonds that form during a type I collision experience an
approximately linear force ramp of 8.3 pN/ms on average
(SD ¼ 1.9). The slope of each plotted force history curve and
the slope of the ﬁrst half of each curve has an average difference
of 3.4% for the six cases. For the case of type III collisions,
the six representative bridging bonds at the time of rupture
experience an average approximately linear force ramp of 7.1
pN/mm (SD ¼ 1.75) (Fig. 7 D). The slope of each plotted
force history curve and the slope of the ﬁrst half of each curve
has an average of 7.0% difference for the six cases.
In Fig. 6 C (type I collision), the average duration over
which a bond bridge experiences a 10-pN linear increase in
bond force is 1.25 ms, whereas in the case of a type III col-
lision (Fig. 6 D), the average lifetime of the bond over the last
10 pN of application of bond force is 2.78 ms. Thus, a linear
ramp of bond force in the range of 6–8 pN/ms on average
results in an increase in bond force of 10 pN over a duration of
FIGURE 6 Bond force-loading histo-
ries of 12 representative bonds for the
case of L-vWF-mediated interplatelet
binding. (A and B) Complete force-load-
ing histories are plotted for interplatelet
bonds that were created during type I (A)
and type III (B) collisions (C and D)
Partial force-loading histories are plot-
ted for the last 10 pN of force, before
rupture, experienced by bonds formed
during type I (C) and type III (D) colli-
sions.
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1–3 ms. The observation of a 10-pN difference in the overall
average bond rupture forces observed in Fig. 5 B corresponds
to a 4.2-ms increase in bond lifetime, as shown in Fig. 5 A.
This is of the same order of magnitude as the time duration
over which a linear force ramp is experienced by the rupturing
bonds for the last 10 pN of force application before failure.
DISCUSSION
Abnormally high hemodynamic shear stresses induce the
binding of freely ﬂowing platelets to circulating plasma vWF.
This pathological occurrence is accompanied by platelet ac-
tivation and formation of platelet thrombi that can critically
hinder blood ﬂow in the narrow regions of the vascular lu-
men. Ultralarge vWF multimers persist in blood in certain
diseased conditions and are found to support shear-induced
platelet aggregation at much lower shear levels in the ﬂuid
than that observed for vWF multimers of average size found
in blood. Shear stress facilitates the interaction between the
GPIba platelet surface receptor and the vWF-A1 domain,
and a critical level of shear stress is required to promote their
association either at the subendothelial surface or in the ﬂuid
with no involvement of a surface.
The multiscale PAD computational model described here
was developed to study the transient aggregation of platelets
via formation of GPIba-vWF-GPIba bond bridges at high
ﬂuid shear rates during the onset of shear-induced patho-
logical thrombosis. Chemical kinetic equations that describe
binding of vWF multimers from solution to GPIba platelet-
surface receptors, as well as reversible vWF-mediated in-
traplatelet and interplatelet cross-linking reactions, were
incorporated into the adhesive dynamics model. The simu-
lation predictions of the efﬁciency of binding between two
colliding platelets (one L-vWF1 and one L-vWF–) were
matched to experimentally derived platelet binding efﬁcien-
cies (29,32,33) by establishing the value of the 2-D cross-
linking bond formation rate constant, the single unknown
parameter of the PAD model, as a function of shear rate. The
PAD model was used to quantify important binding charac-
teristics such as binding efﬁciency, number of interplatelet
bonds formed, bond lifetimes, bond force-loading history,
and bond rupture forces for different types of hydrodynamic
collisions, vWF multimer sizes, and binding kinetics. Such
quantiﬁcations were useful in assessing the individual roles
played by vWF size and kinetic rate constants in the outcome
of interactions between ﬂowing platelets. To our knowledge,
this study is the ﬁrst to consider nonspherical particle binding
reactions, and include the effects of the presence of a plane
wall.
SUMMARY OF RESULTS
Our simulations demonstrate that the extent of binding of
vWF multimers to the platelet surface, as dictated by multi-
FIGURE 7 Bond force-loading histo-
ries of 12 representative bonds for the
case of n-vWF-mediated interplatelet
binding governed by platelet-type VWD
binding kinetics. (A and B) Complete
force-loading histories are plotted for
interplatelet bonds that were created dur-
ing type I (A) and type III (B) collisions
Partial force-loading histories are plotted
for the last 10 pN of force, before rupture,
experienced by bonds formed during
type I (C) and type III (D) collisions.
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mer size and the kinetics of receptor-ligand binding, strongly
governs the ability of two platelets to aggregate, albeit tran-
siently, in high shear ﬂows. The ligand size plays an im-
portant role in determining the platelet receptor occupancy
and therefore the efﬁciency with which a two-platelet colli-
sion results in binding. The forward rate constant was as-
sumed to be the same for all binding scenarios considered at
a particular shear rate. Predicted binding efﬁciencies plotted
in Fig. 4 show that the multimer size itself contributes sig-
niﬁcantly to the success or failure of platelet aggregation.
This is evident from the zero efﬁciency of binding predicted
for n-vWF-mediated platelet aggregation for shear rates
,8000 s1. This result coincides with the experimental ob-
servation of negligible vWF-mediated platelet aggregation
for ﬂuid shear stresses ,80 dyn/cm2 (26,49). The receptor-
ligand binding afﬁnity, the measure of which is the dissoci-
ation constant KD, also strongly inﬂuences the extent of
platelet aggregation, as observed in the case of platelet-type
VWD binding kinetics. Shear-induced platelet aggregation
for the platelet-type VWD case is observed to occur in vitro at
much lower shear rates (1500 s1 and above) compared to
that for the nondiseased condition (54,55). The cross-linking
on-rate may be different for normal and mutant binding ki-
netics, and a larger on-rate can result in more powerful ag-
gregation.
The estimated GPIba-vWF-A1 cross-linking on-rate was
found to increase rapidly with shear rate for values of g .
7200 s1, and more slowly at lower shear rates, in a piece-
wise, linearly dependent fashion, within the range of 4500#
g# 8000 s1. The duration of a cell-cell collision is inversely
proportional to the ﬂuid shear rate, and therefore the same
magnitude of the cross-linking on-rate at a lower shear rate
produces fewer binding events at a higher shear rate. Thus,
either an exponential dependency or piecewise linear de-
pendency of the on-rate on the ﬂuid shear rate coupled with a
sudden increase in slope (6.5-fold in this case) is likely to
explain the pathological in vivo and in vitro observations of
the sudden rise in platelet aggregation at high ﬂuid shear
rates. The properties of transient aggregation of platelets
discussed in this article were found to be highly dependent
on the initial relative positions of the platelets, since this
determines the contact duration and extent of contact be-
tween the surfaces. Hence, for initial conﬁgurations that al-
low even more intimate contact between the platelets than
those considered here, we can expect to observe more ag-
gressive vWF-mediated bridging of the two platelets.
The formation of interplatelet bonds appears to only mod-
estly increase the intimacy of platelet-platelet contact during
a collision. In our simulations, a majority (79%) of the suc-
cessful collisions at 8000 s1 resulted in the formation of a
single bond bridge between two platelets. By positioning the
platelet receptors in clusters on the surface, and providing the
vWF strings with greater mobility in our simulations, for-
mation of a larger number of bond bridges may be expected.
In our simulations, the formation of bond bridges was found
to occur primarily independently, with the formation of a
bond bridge having only a small effect on the probability of
another bond forming. The bond force-loading histories were
found to be highly nonlinear, whereas the bonds were pre-
dicted to rupture under a large linear ramp in tensile force of
magnitude ranging between 6 and 8 pN/ms. The differences
in binding characteristics between the cases of healthy
binding kinetics and diseased binding kinetics speciﬁc to
platelet-type von Willebrand disease were reconciled in a
straightforward manner by studying the bond force histories.
The predicted complex and nonlinear force-loading histories
experienced by interplatelet bonds may be contrasted with
the constant force-loading curves that are typical of bonds
formed between a spherical cell and a surface (10,56).
Assumptions, limitations, and strengths of the
PAD simulation model
Several limitations of this model should be noted. A vWF
multimer bound to a platelet cannot physically reorient itself
with respect to the platelet surface despite 1), formation and
breakage of bonds, i.e., change in ligation with platelet
GPIba receptors during the course of the simulation, and 2),
the effect of ﬂuid forces on the ligand molecules in high shear
ﬂow. Another limitation is the inability of the simulated vWF
molecules to protrude from the platelet surface as loose
strings. Such protrusions effectively increase the surface
capture area of a ﬂowing platelet. Incorporation of ﬁnite-
volume vWF particles can resolve these deﬁciencies of the
model. In our simulations, vWF multimers distributed about
the platelet surface and present in solution were monodis-
perse. There exists in blood a large polydispersity of vWF
multimers. The size distribution of plasma vWF multimers is
approximately Gaussian, with a slight skew toward the
larger-sized multimers (40). We selected the average size of
vWF as representative of the normal distribution of vWF in
plasma. Abnormal presence of ULVWF and L-vWF in blood
increases the apparent average size of circulating vWF. One
of the largest vWF sizes normally present in plasma was
selected to represent this pathological condition. For these
reasons, and also for the sake of simplicity, we conducted
platelet aggregation simulations by assuming monodispersity
of ligand.
Although the simulation predictions of transient binding
were matched to the experimental observations of stable
aggregation, a 1:1 correspondence may not exist between
platelet aggregation and platelet-platelet binding via GPIba-
vWF-A1 binding interactions. Bond lifetimes, number of
bonds formed, and spatial distribution of bonds may affect
the probability of the platelet and its aIIbb3 receptors being
activated and forming aIIbb3-vWF bonds, or the manner in
which this occurs. Platelet activation leads to ADP secretion,
which can also inﬂuence the aggregation rate in experimental
studies. Although numerous experimental studies have
quantiﬁed the extent of aggregation of platelets at high shear
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rates, these data cannot be applied here, as the fraction of
platelets that enter aggregate formation is dependent on 1),
the collision behavior of the cells, and therefore the ﬂow
geometry of the experimental apparatus, and 2), the duration
of the experiment.
GPIba-vWF binding is incapable of mediating the for-
mation of stable platelet aggregates (28). Our simulations
show that interplatelet GPIba-vWF-GPIba bond bridges are
short-lived and cannot overcome the dominating shearing
forces that quickly separate the transient platelet aggregate.
Although the fraction of high-shear-induced vWF-positive
platelets is small compared to the total platelet population that
is sheared in the presence of vWF multimers (28,29), Goto
et al. (28) demonstrated that all vWF-positive platelets gen-
erated in a high-shear environment participate in aggregate
formation. This supports our assumption that interplatelet
bridge formation via GPIba-vWF association will immedi-
ately or eventually result in creation of stable platelet ag-
gregates mediated by aIIbb3 platelet receptors. Despite the
inability of the GPIba-vWF bond to support stable inter-
platelet connections, this is the sole interaction that possesses
the mechanical strength to sustain initial interplatelet contact
under high shear ﬂow (42). Such transient interplatelet as-
sociations are not only responsible for inducing aIIbb3 re-
ceptor activation, but also promote aIIbb3-receptor-mediated
platelet bridging via vWF or ﬁbrinogen. Platelets activated by
exogenous agonists are also unable to ‘‘see’’ one another
when subjected to high shear rates unless platelet-platelet
bridging by GPIba-vWF-GPIba bonds ﬁrst occurs (42).
GPIba exists as a subunit of the GPIb-IX-V complex. This
association of multiple molecules is expected to slow down
its diffusion rate (57). In addition, a fraction of these mole-
cules may be immobile on the surface due to various con-
straining factors. About 15% of these complexes present on
the surface are found to be located in rafts on the resting
platelet surface (58). The cytoplasmic domain of GPIba is
known to interact extensively with the cytoskeleton. Dong
et al. (59) showed that this interaction plays an important role
in regulating the receptor mobility. It was found that wild-
type GPIb-IX complexes demonstrated negligible mobility in
Chinese hamster ovary cells. In contrast, there was a marked
increase in receptor mobility of mutant GPIb-IX complexes
containing varying degrees of truncation of the receptor cy-
toplasmic domain. Accordingly, we did not incorporate
‘‘receptor diffusivity’’ into our transient platelet aggregation
model, and the GPIba receptors were assumed unable to
freely diffuse about the platelet surface. Bell (48) showed that
cross-linking reactions between cells are indeed possible
even when receptors are immobile if the participating ligand
is long and ﬂexible, as is the case here.
Our model disregards the Brownian motion of vWF mol-
ecules. Diffusion of these submicron particles has the po-
tential to inﬂuence the dynamics of binding and unbinding by
1), increasing the probability of close encounters between
ligand molecules and surface receptors, which can lead to
correct positioning of the molecules for binding with the
surface receptors, thereby promoting bond formation (60),
and 2), disrupting bonds due to bond stressing (61). These
particles are nonspherical and reasonable Brownian motion
estimates can be made by either simulating vWF as real
particles, performing Brownian dynamics simulations (62),
or including expressions that account for bidisperse particle
encounters due to diffusive mechanisms (60).
A platelet aggregation model that included the hydrody-
namic effects of sphere-sphere collisions and deterministic
rate equations governing aIIbb3 binding to ﬁbrinogen (the
linker molecule between two platelets) was proposed by
Tandon and Diamond (63). They demonstrated that hydro-
dynamic interaction itself accounts for a signiﬁcant reduction
in the collision efﬁciency and therefore plays a key role in
governing the success of a collision. A successful collision
was deﬁned as one in which the total number of bonds that
formed between the two cells was greater than a predeﬁned
critical number based on the estimate for the ﬂuid drag force
acting to break the bonds, which was considered invariant
with time. A number of simpliﬁcations were made in deter-
mining the receptor efﬁciency. A critical number of receptor-
ﬁbrinogen-receptor bonds were derived by assuming that all
bonds are simultaneously stressed in equal measure. The
effects of single or multiple bond formation and breakage on
the modiﬁcations of cell trajectories were not included, and
bond rupture due to external forces acting on the bonds was
not addressed. This is a simpliﬁed picture of the binding re-
quirements for aggregation, and a more relevant visualization
can be obtained by considering the physical location of the
bonds on the cell surface and the number of bonds present at
any time. Our simulation model addresses these simpliﬁca-
tions by tracking the physical location and properties of every
platelet-platelet bond present in the ﬂuid system, and one can
therefore view a snapshot of the entire physical state of the
system at every time step. However, the PAD model pro-
posed here only accounts for interactions between two single
platelets and does not model encounters between a platelet
and an aggregate of two or more platelets, a fundamental and
important feature of Tandon and Diamond’s hydrodynamic
model.
Mechanisms by which shear stress enhances
GPIba-vWF association and platelet activation
Platelet activation as a result of platelet-vWF binding is
vWF-size-dependent and occurs only when vWF is in
multimeric form (64). High-shear-induced binding of mul-
tivalent vWF to unbound platelets has been shown to cause
a transmembrane calcium inﬂux that activates the cell and
thereby switches the aIIbb3 receptor binding state from in-
active to active (64). It is important to note that shear stress
by itself, or the exposure of platelets to high shear and
monomeric vWF molecules in suspension, is incapable of
inducing intracellular calcium increase and therefore cannot
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promote platelet activation or aIIbb3-receptor-mediated
aggregation (49,64). The binding reaction between GPIba
and vWF-A1 alone is thus insufﬁcient to promote platelet
activation and the additional application of some critical
force at the site of attachment to the GPIba receptors on the
platelet surface appears to be a requirement for successful
outside-in signaling to activate the cell. Although the exact
mechanism of platelet-vWF binding that triggers the sig-
naling event is currently unresolved, it has been speculated
that one or more of the following three shear-induced
platelet-vWF binding mechanisms may be responsible for
the onset of platelet activation: 1), a vWF multimer larger
than a critical size when bound via a single receptor-ligand
bond to a platelet may experience sufﬁcient shearing force
and thereby apply a mechanically activating force on the
transmembrane domain of the bound receptor; 2), cross-
linking reactions of a vWF multimer with two or more
platelet receptors may trigger the signaling event either
through application of greater mechanical force on the re-
ceptors or via receptor clustering; and 3), cross-linking re-
actions that mediate interplatelet contacts, which generate
considerably larger forces at the sites of attachment on both
platelets compared to the ﬁrst two cases listed above (28).
Shankaran et al. (49) have shown that shear stress level
rather than interplatelet contact frequency appears to be
the dominant factor responsible for the platelet activation
process. Detailed simulations of ﬁnite-volume vWF-platelet
binding incorporated in single-platelet and multiplatelet
adhesive dynamics simulations can help estimate the forces
experienced by platelet-vWF bonds that result from particle
translation and rotation in shear ﬂow.
The effects of increasing shear stress on the rate of GPIba-
vWF bond formation have not been quantiﬁed to date.
Crystal structure studies of the wild-type and mutant GPIba
N-terminal domain and A1 domain of vWF have revealed
some key insights into the physical mechanisms of shear-
dependent activation (13,15,65), demonstrating that possi-
bly a critical level of shear force imparted by blood ﬂow
can sufﬁciently perturb the conformational structure of the
platelet receptor and/or vWF molecules to expose the ap-
propriate binding site(s), and when this happens, bond for-
mation is greatly favored. Contradictory observations
(38,49,62,66,67) have made it hard to clarify whether un-
folding of vWF protein from a globular conformation to an
extended-chain state actually occurs, either in solution or
when bound to the subendothelial surface, under the action of
shear stress. Fluid shear stress is thus expected to be an im-
portant parameter that inﬂuences the on-rate/off-rate kinetics
of this receptor-ligand pair. Note that the shear-stress-
dependent mechanism of GPIba-vWF binding is believed to
be the same for either platelet-wall adhesion or platelet
binding to circulating vWF (2). When subjected to the same
ﬂuid shear rate, the shear forces that act on the cells and
protein surfaces in force-free and torque-free ﬂow are com-
paratively much smaller compared to the ﬂuid forces expe-
rienced by stationary platelets or vWF that are in contact with
or bound to the surface (3,4).
The equilibrium binding state, as deﬁned by KD, is possi-
bly a function of the ﬂuid shear rate. However, since little is
known about the forward rate constant and binding afﬁnity as
a function of the shear level in the ﬂuid, the parameter KD,
which governs the initial vWF distribution on a platelet when
the simulation initializes, was kept constant with respect to
shear rate. It is possible that within the time taken for equi-
librium binding to occur the platelet may activate and ag-
gregate and this may involve associated phenomena such as
shape change and degranulation. We chose, however, to
initiate our simulations with equilibrium binding criteria
since quantiﬁcation of binding equilibria has been carried out
by various research groups to a limited extent. Knowledge of
the equilibrium binding state alone (as opposed to a kinetic
model) is found to be sufﬁcient in numerous models of re-
ceptor occupancy and cell signaling (47). On the other hand,
there is a paucity of studies that measure or estimate the
GPIba-vWF association rate constant. Importantly, binding
equilibrium conditions characterize the nature of binding as a
function of vWF size and the binding kinetics. The focus of
the present study was on simulating binding of vWF-positive
platelets to other platelets to determine the effects of platelet
shape, vWF size and binding kinetics on the biophysical
aspects of platelet-platelet binding. The interaction of ini-
tially unligated platelets and vWF at high shear that leads to
binding of vWF to the platelet surface is a separate kinetic
study in its own right in which the model’s binding param-
eters must be matched to an additional set of kinetic data
plotted as a function of time. Although konL is calculated in
our model, it is a simple approximation and not of critical
importance to the kinetics of interplatelet binding for simu-
lations of suitably short durations since initial equilibrium
binding is already achieved.
L-selectin- and P-selectin-mediated rolling of leukocytes
exhibit the shear threshold phenomenon, which is charac-
terized by leukocyte tethering to vascular endothelium only
above a certain critical ﬂuid shear stress and by absence of
tethering at local ﬂuid shear stresses below the critical
threshold. This shear threshold behavior has been recently
resolved by a proposed two-state catch-slip model that de-
scribes the single-bond dissociation kinetics for selectins
with its corresponding ligand (68). This model is character-
ized by two distinct bond dissociation pathways: 1), fast
dissociation (weak binding) when the bond is negligibly
stressed, and 2), slow dissociation (strong binding) when the
bond is adequately stressed. To date, only the Bell model has
been used to describe the GPIba-vWF dissociation kinetics,
and it does not account for the shear threshold effect ex-
hibited by unactivated platelet interactions with surface-
bound vWF. There is a critical need for the development of
GPIba-vWF binding kinetic models that are of greater
physiological relevance, since the shear threshold effect is a
central theme in platelet-vWF binding both in solution
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(pathological thrombosis) and at the subendothelial surface
(hemostasis). Introduction of such improved kinetic equa-
tions in computer simulations of platelet binding to surface-
bound vWF, as well as vWF in suspension, will perhaps
enable recreation of platelet adhesive behavior with greater
reliability and accuracy, providing better insight into the ef-
fects of ﬂuid shear forces on platelet adhesive dynamics.
CONCLUSIONS
The development and application of the PAD model enabled
us to obtain the following insights into platelet-platelet hy-
drodynamic and adhesive interactions in physiologically and
pathologically relevant environments:
1. The physics of cell-cell collisions are a strong function of
particle shape and proximity of physical ﬂow boundaries,
which strongly inﬂuence the fate of platelet-platelet
encounters in the ﬂuid. In particular, 1), homogeneous
platelet (oblate spheroid) collision frequency increases by
25% when platelets far from any bounding surface are
brought in close proximity to a wall (reactive gap ¼ 128
nm); and 2), heterogeneous platelet-sphere (equal vol-
ume) collision frequency is 21% greater than homoge-
neous platelet collision frequency and 30% greater than
homogeneous sphere collision frequency near a bounding
wall (reactive gap ¼ 128 nm).
2. A shift in average vWF ligand size in plasma to higher
values, or reduction in the dissociation constant KD that
describes GPIba-vWF-A1 binding kinetics strongly in-
ﬂuences the equilibrium binding kinetics and corre-
spondingly increases platelet-platelet binding efﬁciency.
Pathological consequences such as shear-induced platelet
aggregation at shear rates (,5000 s1) normally encoun-
tered in vivo can result.
3. The GPIba-vWF-A1 bond formation rate is predicted to
have piecewise linear dependence on the prevailing shear
rate in the ﬂuid such that the rate of association is a
strong function of shear rate at _g. 7200 s1 and a weak
function of shear rate at _g, 7200 s1:
4. GPIba-vWF-A1 bond lifetimes and bond rupture forces
at _g ¼ 8000 s1 were found to be of very short duration,
20–40 ms and ;70 pN, respectively, for normal binding
kinetics. Bond lifetimes appear to be an increasing
function, and rupture forces appear to be a decreasing
function, of the collision property, time integral of contact
area.
5. The force-loading curves for bond linkages that bind
two platelet cells together in ﬂow are highly complex
and nonlinear. All GPIba-vWF-A1 bonds ruptured at
_g ¼ 8000 s1 under a very high linear force ramp of 6–8
pN/ms.
Models such as PAD that integrate particle-particle and
particle-wall hydrodynamic effects and molecular level ad-
hesive dynamics that govern stochastic cell-cell and cell-
vascular wall adhesive interactions can be linked with pre-
dictive cell signaling models to simulate cell activation,
probability of formation of integrin-ligand bonds, and release
of granule contents from the platelet, leading to the devel-
opment of a fully prothrombotic environment. Knowledge of
the critical number of GPIba receptors on a platelet surface
required for binding one or more vWF multimers to bring
about platelet activation, or the time lapse between binding of
GPIba to vWF and subsequent activation are needed to
further our understanding of initial platelet activation. The
scope of our study of platelet-platelet binding in solution via
GPIba-vWF-GPIba bond bridging is somewhat limited by
the dearth of experimental results available. As we increase
our quantitative knowledge of platelet function and behavior
through experimentation, the spectrum of physiological and
pathological phenomena that can be computationally mod-
eled will continue to expand.
APPENDIX A: PLATELET-VWF BINDING
EQUILIBRIUM: USE OF THE EQUIVALENT SITE
HYPOTHESIS (ESH) MODEL
GPIba-vWF KD values reported in the literature
KD values for GPIba-vWF binding have been experimentally determined
by a number of research groups using static binding assays. Monomeric
vWF-A1 binding to GPIba has been measured (13,43,69). KD was found to
be approximately 3.3 3 106 M and 3.0 3 106 M in two independent
experimental studies (43,69) and 3.03 108 M in a third study (13). Miura
et al. (43) also determined that the KD for plasma vWF binding to im-
mobilized GPIba was 3.4 mM. Several research groups determined
the KD value for vWF multimer binding to platelets in the presence of
ristocetin, a nonphysiological modulator; KD was found to be#20 nM in all
cases (20,28,70). Larger multimers were consistently observed to have
higher platelet afﬁnities that resulted in increased platelet aggregation
(17,19,20,22,71). This correlation between multimer size and binding
activity is also seen in the case of vWF binding to other biomolecules
such as heparin and ﬁbrin (72,73). The mechanism of vWF binding to
suspended platelets in the presence of ristocetin is different from that
involved in shear-induced platelet-vWF binding (42). Also, KD for platelet
GPIba-vWF binding is possibly a function of the shear rate prevalent in the
local ﬂuid environment.
Testing ESH equilibrium model using KD values
from the literature
The KD value of multimeric vWF is assumed here to be equal to the single-
site dissociation constant KD of monomeric vWF-A1. Goldstein and Wofsy
(74) derived a method for relating the two-dimensional cross-linking equi-
librium constantKX to the three-dimensional equilibrium constant:KX¼ KA/d,
where d is the average distance between two binding sites on the ligand.
We follow themethod of English and Hammer (75) for the estimation of d for
a multivalent ligand. We assume that all binding sites are accessible for
ligation with platelet surface receptors. Although this may be an oversim-
pliﬁcation, little is known about the vWF equilibrium cross-linking constant,
and the space sampled by free A1 binding sites of vWF molecules bound to
receptors on a cell surface, and hence this straightforward estimation is made
to preserve clarity and simplicity of the model. For a vWFmolecule modeled
as a prolate spheroid of dimensions 175 3 28 nm,
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Using the above values to solve Eqs. 1 and 2, we obtain the number of free
receptors/cell,Req¼ 898, and the total number of vWFmolecules bound/cell¼
1899. Only 8.4% of the receptors are available for binding vWF multimers
present on the surface of another platelet. The ESHmodel predicts strong and
intense binding of vWF in solution to platelets at equilibrium. Such intense
platelet-vWF binding is not intuitively expected given that at physiological
shear rates, free vWF does not bind platelets, and at pathologically high shear
rates the fraction of ‘‘vWF-positive’’ platelets is ,0.05 at a shear rate of
12,000 s1 (29).
English and Hammer (75) developed a model for viral docking to a cell
surface in which the Brownian motion of a multivalent spherical ligand
(virus) was simulated near a ﬂat surface (cell) along with the dynamics of
receptor-ligand adhesion. Viral docking was quantiﬁed and compared with
the prediction of the ESH model. It was shown that the ESH model is an
unsuitable model for predicting viral binding to cells due to its gross
overprediction of the binding of virus particles to cells, especially of the
number of bonds formed between each ligand and the cell surface. Although
the virus was modeled as a rigid sphere in English and Hammer’s adhesive
dynamics simulations, vWF is a linear ﬂexible loosely coiled molecule, and
stronger binding may be observed for ﬂexible and stringy molecules than for
rigid spheres, since rigidity of particle shape and relative receptor location on
the particle surface increases the difﬁculty of additional bond formation
despite particle Brownianmotion. Here, the overprediction of the bound state
is attributed to use of an inappropriate KD that does not correctly represent
shear-induced binding in solution.
Determination of a suitable KD value for
shear-induced binding of GPIba to vWF
Goto et al. (28) studied the binding of vWF to platelets in the presence
of ristocetin and observed that an initial vWF solution concentration of
10 mg/ml led to the binding of 30,000 vWF subunit molecules/platelet. KD
was found to be 5.3mg/ml, which for an 18-mer (260 kD per monomer) vWF
solution yields KD¼ 1.13 nM. The ESHmodel predicts Req¼ 0; Ceq¼ 2067
for a vWF solution concentration of 10 mg/ml. The maximum number of
vWF multimers bound experimentally was found to be 42,125 vWF subunit
molecules/platelet at an initial vWF solution concentration of 60mg/ml. If on
average each vWF molecule possesses 18 subunits, then the number of
bound vWF molecules¼ 2340 per platelet. This maximum number of bound
vWFmolecules per platelet depends on the number of receptors/platelet and the
average number of receptors bound/vWF molecule. The ESH model predicts
Req ¼ 0; Ceq ¼ 2425 vWF molecules (RT ¼ 10688 GPIba receptors/platelet)
bound to each platelet for a vWF solution concentration of 60 mg/ml, which
is 3.6% greater than the experimental observation. We conclude that the ESH
model may be suitable for predicting vWF equilibrium binding conditions.
Under shear-induced binding of vWF to platelets (28), ;907 vWF
subunit molecules/platelet (907/18¼ 50 vWFmolecules) were found to bind
at an initial vWF concentration of 10 mg/ml at 10,800 s1. The experiments
of Goto and co-workers show that shear-induced vWF binding at a vWF
solution concentration of 10 mg/ml is 33 times less than ristocetin-induced
binding. The ESH model, which predicted 2067 bound vWF molecules/
platelet for risotcetin-induced binding should then predict the binding of
2067/33¼ 63 vWF molecules/platelet at equilibrium. This equilibrium state
is predicted by the ESH model if a KD value of 7.733 10
5 M, obtained by
trial and error, is used.
APPENDIX B: EQUILIBRIUM BINDING
CONDITIONS FOR OTHER (PATHOLOGICAL)
CASES OF VWF-PLATELET BINDING AS
PREDICTED BY THE ESH MODEL
L-vWF-mediated binding
Using the value of KD determined above and L0 ¼ 2.0 nM, the binding of a
large vWF molecule (L-vWF) is calculated. We obtained Req ¼ 8272 and
Ceq,1¼ 7; Ceq,2¼ 25; Ceq,3¼ 56; Ceq,4¼ 85; Ceq,5¼ 97; Ceq,6¼ 85; Ceq,7¼
59; Ceq,8 ¼ 32; Ceq,9 ¼ 14; Ceq,10 ¼ 5; Ceq,11 ¼ 1; Ceq,12–17 ¼ 0, and Ceq ¼
466 vWFmolecules. For this case, L in solution changes by 10.6%. Since the
change in ligand concentration in solution is substantial, the analytical
solution for equilibrium binding, which is based on constant ligand concen-
tration in solution, may not be valid.
n-vWF-mediated binding with platelet-type VWD
binding kinetics
Binding kinetics for type 2B-VWD or platelet-type vWD is characterized by
smaller bond dissociation rates and/or enhanced bond formation rates.
Binding studies have shown that gain-of-function point mutations in the
A1 binding domain of vWF or in the GPIba binding domain cause a 3- to 20-
fold decrease in the dissociation constant,KD, for platelet-surface binding via
GPIba-vWF-A1 interaction (10,43).We assume a ﬁvefold decrease inKD for
the platelet-type VWD binding model that results from a ﬁvefold decrease in
the off-rate (14,43). For KD ¼ 1.553 105 M and L0 ¼ 2.0 nM, the binding
of n-vWF molecules is calculated. We obtain Req ¼ 4287 and Ceq,1 ¼ 10;
Ceq,2¼ 50; Ceq,3¼ 144; Ceq,4¼ 269; Ceq,5¼ 334; Ceq,6¼ 277; Ceq,7¼ 147;
Ceq,8 ¼ 46; Ceq,9 ¼ 6; and Ceq ¼ 1283 vWF molecules. For this case, L in
solution changes by 29%.
Explicit solution of the kinetic equations
governing multivalent ligand binding to platelet
receptors for those cases in which the analytical
equilibrium solution is not valid
The kinetic equation set of the ESH model for multivalent ligand binding to
cell surface receptors is as follows (57):
dL
dt
¼vkfLR1krC1
dC1
dt
¼ vkfLR krC1ð f 1ÞkxC1R12kxC2
dCi
dt
¼ ð f  i11ÞkxCi1R ikxCið f  iÞkxCiR
1ði11ÞkxCi11 for i¼ 2to f 1
dCf
dt
¼ kxCf1R fkxCf
R¼RT+
f
i¼1
iCi; (B1)
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where L is the time-varying ligand concentration in solution, kx is the two-
dimensional cross-linking forward rate constant, and kx is the two-
dimensional cross-linking reverse rate constant. For time-varying L, these
f1 2 equations containing f1 2 unknowns can only be solved numerically.
We tested the numerical algorithm employed (Runge-Kutta fourth-order
method) for solving Eq. B1 by comparing the solution for equilibrium
binding behavior for an n-vWF-platelet system obtained from the numer-
ical solution of the kinetic equations (Eq. B1) with that calculated using the
analytical solutions given by Eqs. 1 and 2. Both the analytical and numeric
solutions were found to be the same. Solution of the kinetic equations to
determine equilibrium binding also reveals the time duration over which
equilibrium is established, which is 25 s for this system (C1, C2, . . ..Cf ¼ 0
specify the initial conditions). Solving Eq. B1 numerically for an L-vWF-
platelet system, we ﬁnd that the analytical solution for constant solution
ligand concentration overpredicts L-vWF multimer binding to platelets
by 4.95%. The numerical solution for equilibrium binding is Req ¼ 8373
and Ceq,1 ¼ 7; Ceq,2 ¼ 23; Ceq,3 ¼ 52; Ceq,4 ¼ 80; Ceq,5 ¼ 92; Ceq,6 ¼ 82;
Ceq,7¼ 57;Ceq,8¼ 31;Ceq,9¼ 14; Ceq,10¼ 5; Ceq,11¼ 1; Ceq,12–17¼ 0; and
Ceq¼ 444 vWF molecules. For this case, L in solution changes by 10.15%.
Again solving Eq. B1 for the platelet-type VWD system, the solution at
equilibrium is Req ¼ 4519 and Ceq,1 ¼ 8; Ceq,2 ¼ 40; Ceq,3 ¼ 122; Ceq,4 ¼
240; Ceq,5¼ 314; Ceq,6¼ 274; Ceq,7¼ 154; Ceq,8¼ 50; Ceq,9¼ 7 and Ceq¼
1209 vWF molecules. L in solution changes over the course of binding by
27.6%. The analytical solution given by Eqs. 1 and 2, which assumes L ¼ Lo,
overpredicts the binding of vWF multimers to diseased platelets by 6.12%.
APPENDIX C: CALCULATION OF FORWARD
RATE CONSTANT FOR VWF ASSOCIATION WITH
PLATELET SURFACE RECEPTOR GPIBa
The intrinsic forward rate constant for GPIba binding to vWF in solution can
be calculated as
k
0
on¼
k
o
r
KD
¼ 5:47s
1
7:733105M
¼ 70;763M1 s1; (C1)
where kor ¼ 5:47 s1 is the unstressed off-rate (11). Next, we determined the
importance of diffusion in controlling the reaction (binding) rate. The
forward transport rate constant for ligand molecules diffusing to a spherical
cell surface is ðkdiffÞcell ¼ 4pDLa and the forward reaction rate constant is
ðk0onÞcell ¼ Rk0on; where DL ¼ 4.53 108 cm2/s (40) is the average diffusion
coefﬁcient of vWF, a¼ 0.63 mm is the radius of a sphere with volume equal
to that of a platelet of size 2 3 2 3 0.5 mm3, and R is the number of free
receptors on the cell surface. The overall forward rate constant for ligand
association per cell surface receptor is (for R ¼ Req(n-vWF)) (57)
kon¼ ðkdiffÞcellk
0
on
ðkdiffÞcell1Rk0on
¼ ð2:146310
10
M
1
s
1Þð70;763M1 s1Þ
ð2:14631010M1 s1Þ110;482ð70;763M1 s1Þ
¼ 60;983M1 s1 (C2)
and, konL ¼ 1.22 3 104 s1.
Although these calculations were made considering a spherical geometry, it
is assumed that this method of calculation for kon is approximately valid even
for a cell shape in which the particle diameter is smaller in one of threemutually
orthogonal directions with respect to the Cartesian coordinate system.
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